Video

M. Preusser discusses the molecular markers that should be routinely assessed and biomarker-driven algorithm for glioma treatment. Furthermore, he covers currently standardised molecular techniques, importance of quality control in molecular testing, and molecular markers that are currently under investigation in glioma and other primary brain tumours.